Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01136_DB06414_nanopub.RAfv9MU3ayylfEHfnngbHK1Jafl73p18urQsL3icD3X4M#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01136_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01136_DB06414 label "DDI between Carvedilol and Etravirine - Carvedilol, when used concomitantly with etravirine (a CYP2C9 inhibitor), may experience an increase in serum concentration. It is recommended to monitor for signs and symptoms of an increased response to carvedilol, such as orthostatic hypotension and bradycardia. [drugbank_resource:DB01136_DB06414]" assertion.
- drugbank_resource:DB01136_DB06414 identifier "drugbank_resource:DB01136_DB06414" assertion.
- drugbank_resource:DB01136_DB06414 title "DDI between Carvedilol and Etravirine - Carvedilol, when used concomitantly with etravirine (a CYP2C9 inhibitor), may experience an increase in serum concentration. It is recommended to monitor for signs and symptoms of an increased response to carvedilol, such as orthostatic hypotension and bradycardia." assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01136_DB06414 assertion.
- drugbank:DB01136 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01136_DB06414 assertion.